多中心、随机、Ⅱ期 PEACE V-STORM 试验：确定寡复发淋巴结转移前列腺癌最佳挽救治疗方案。
The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases.
机构信息
Department of Radiation Oncology, Geneva University Hospital, Geneva, Switzerland.
Department of Radiation Oncology, Iridium Kankernetwerk, Antwerp, Belgium; University of Antwerp, Faculty of Medicine and Health Sciences, Antwerp, Belgium.
出版信息
Eur Urol Focus. 2021 Mar;7(2):241-244. doi: 10.1016/j.euf.2020.12.010. Epub 2020 Dec 29.
PMID:33386290
Abstract
Optimal local treatment for nodal oligorecurrent prostate cancer is unknown. The randomized phase 2 PEACE V-STORM trial will explore the best treatment approach in this setting. Early results on the acute toxicity profile are projected to be published in quarter 3, 2021.
摘要
局部治疗寡转移前列腺癌的最佳方法尚不清楚。正在进行的 PEACE V-STORM 试验将探索该治疗策略的最佳方法。预计 2021 年第 3 季度公布该试验的急性毒性特征的早期结果。
Zotero 插件